Latest Period
Q1 2026
Security Snapshot
Traws Pharma, Inc. - Common Stock, par value $0.01 per share (TRAW) Institutional Ownership
CUSIP: 68232V884
13F Institutional Holders and Ownership History from Q3 2024 to Q1 2026
Institutions Reporting
27
Shares (Excl. Options)
3,619,796
Price
$1.83
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Symbol
- TRAW on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 3,619,796
- Total 13F value
- $6,624,230
- Portfolio coverage rank
- 0%
- Share change
- +201,203
- Value change
- +$459,630
- Number of holders
- 27
- Shares outstanding
- 16,062,541
- SEC-reported price per share
- $1.53
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- TRAW - Traws Pharma, Inc. - Common Stock, par value $0.01 per share is tracked under CUSIP 68232V884.
- 27 institutions reported positions in Q1 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 21 to 27 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $3,863,003 to $6,624,230.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 27 institutions filings for Q1 2026.
Security key
68232V884
Latest holder period
Q1 2026
13F holders
27
13D/G owners
8
CIK / CUSIP context first
Open Q1 2026 holders
TRAW full holder history
Traws Pharma, Inc. SEC filings
Traws Pharma, Inc. company facts
Traws Pharma, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 68232V884:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
TRAW
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 12% | -40% | $3,431,754 | +$2,040,131 | 1,876,198 | +147% | ORBIMED ADVISORS LLC | 16 Apr 2026 |
| PERCEPTIVE ADVISORS LLC | 6.1% | -39% | $1,793,061 | +$170,058 | 979,815 | +10% | Perceptive Advisors LLC | 31 Mar 2026 |
| Ikarian Capital, LLC | 10% | 0% | $1,308,164 | +$359,065 | 812,524 | +38% | Ikarian Capital, LLC | 31 Dec 2025 |
| Adage Capital Management, L.P. | 9.1% | +89% | $1,175,300 | +$644,000 | 730,000 | +121% | Adage Capital Management, L.P. | 31 Dec 2025 |
| Chernett Jorey | 6.8% | $668,220 | 543,268 | Chernett Jorey | 14 Jan 2026 | |||
| Squadron Capital Management LLC | 6.4% | -28% | $936,437 | -$369,342 | 511,714 | -28% | Squadron Master Fund LP | 31 Mar 2026 |
| Ayrton Capital LLC | 4.3% | -56% | $552,125 | -$97,751 | 342,935 | -15% | Ayrton Capital LLC | 31 Dec 2025 |
| Alyeska Investment Group, L.P. | 9.9% | $462,446 | 302,252 | Alyeska Investment Group, L.P. | 31 Dec 2024 |
As of 31 Mar 2026, 27 institutional investors reported holding 3,619,796 shares of Traws Pharma, Inc. - Common Stock, par value $0.01 per share (TRAW). This represents 23% of the company’s total 16,062,541 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
23%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.5% | 730,000 | 0% | 0% | $1,335,900 |
| Ikarian Capital, LLC | 4.2% | 678,142 | 0% | 0.18% | $1,241,000 |
| ORBIMED ADVISORS LLC | 3.8% | 605,531 | 0% | 0.03% | $1,108,122 |
| Squadron Capital Management LLC | 3.2% | 511,714 | -28% | 0.37% | $936,437 |
| Dauntless Investment Group, LLC | 2.6% | 416,998 | 2.1% | $763,106 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 1.2% | 194,536 | 0% | 0.01% | $356,001 |
| ADAR1 Capital Management, LLC | 0.96% | 154,098 | -0.22% | 0.02% | $281,999 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.48% | 77,103 | +25% | 0% | $141,100 |
| Palumbo Wealth Management LLC | 0.38% | 61,175 | 0.03% | $111,951 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.34% | 55,193 | 0% | 0% | $101,003 |
| VANGUARD FIDUCIARY TRUST CO | 0.2% | 31,804 | 0% | 0% | $58,201 |
| STATE STREET CORP | 0.16% | 25,802 | 0% | 0% | $47,218 |
| JANE STREET GROUP, LLC | 0.13% | 21,241 | 0% | $38,871 | |
| TWO SIGMA INVESTMENTS, LP | 0.12% | 19,244 | 0% | 0% | $35,217 |
| Lynx1 Capital Management LP | 0.09% | 15,078 | 0% | $27,593 | |
| BlackRock, Inc. | 0.06% | 9,956 | 0% | 0% | $18,219 |
| UBS Group AG | 0.03% | 4,053 | -48% | 0% | $7,417 |
| Tower Research Capital LLC (TRC) | 0.02% | 3,964 | 0% | $7,254 | |
| MORGAN STANLEY | 0.02% | 3,729 | 0% | $6,824 | |
| Vanguard Global Advisers, LLC | 0% | 262 | 0% | 0% | $479 |
| SBI Securities Co., Ltd. | 0% | 128 | -21% | 0% | $234 |
| FMR LLC | 0% | 23 | +1050% | 0% | $42 |
| Cassaday & Co Wealth Management LLC | 0% | 11 | 0% | $21 | |
| Robinswood Financial LLC | 0% | 5 | 0% | 0% | $9 |
| JONES FINANCIAL COMPANIES LLLP | 0% | 2 | 0% | $4 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
7
Latest
Q1 2026
Rows shown
1-7 of 7
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 3,619,796 | $6,624,230 | +$459,630 | $1.83 | 27 |
| 2025 Q4 | 3,418,588 | $3,863,003 | +$1,409,923 | $1.13 | 21 |
| 2025 Q3 | 1,304,595 | $2,413,244 | +$101,966 | $1.85 | 18 |
| 2025 Q2 | 1,263,487 | $1,869,962 | -$1,075,287 | $1.48 | 19 |
| 2025 Q1 | 1,732,309 | $3,984,315 | +$1,207,345 | $2.30 | 18 |
| 2024 Q4 | 1,141,975 | $10,140,752 | +$4,400,867 | $8.88 | 17 |
| 2024 Q3 | 646,356 | $3,800,574 | +$3,742,033 | $5.88 | 10 |